EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis

Meiling Jing, Xiaohan Zhu, Yueyi Yang, Xuchen Hu, Wenduo Tan, Xiaoyu Liu, Yujie Zhang, Xin Wang, Chenguang Niu, Zhengwei Huang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202600222rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Meiling Jing und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Osteoporosis, Osteogenesis, Osteoblasts, Osteoclasts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality (STCSM), Shanghai Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a prevalent systemic skeletal disorder that leads to bone fragility and an elevated risk of fractures. Osteomodulin (OMD) is recognized for its essential role in bone morphogenetic protein 2 (BMP2)‐driven osteogenic differentiation. However, its role in osteoporosis, has not been systematically investigated. Here, we carried out omics studies on osteoporotic data obtained from the NCBI database and showed that OMD is mainly expressed in osteoprogenitor cells and that OMD expression levels are down‐regulated under bone loss conditions. OMD osteoblast‐specific conditional knockout mice ( OSTEOCALCIN‐Cre (OC‐Cre) ; Omd flox/flox ) were generated by CRISPR and an ovariectomy (OVX)‐induced model of osteoporosis was constructed in mice. Micro‐CT of OVX mice indicated that the trabecular bone volume fraction (BV/TV) was significantly decreased in OC‐Cre ; Omd flox/flox mice. Tartrate resistant acid phosphatase (TRAP) staining showed an increase in the number of osteoclasts in the femurs of OC‐Cre ; Omd flox/flox mice. TRAP and immunofluorescence staining indicated that OMD treatment inhibited osteoclast differentiation of bone marrow‐derived macrophages (BMDMs) in vitro. RNA sequencing showed that OMD treatment significantly affected osteoclast differentiation signaling pathways, while western blot analysis revealed that OMD treatment decreased the phosphorylation of JNK, ERK, p38, AKT, and IκBα in BMDMs. Molecular docking analysis predicted that OMD binds to receptor activator of nuclear factor kappa beta ligand (RANKL), which was verified by co‐immunoprecipitation. Further molecular docking simulations indicated that OMD shares overlapping binding regions on RANKL with osteoprotegerin and RANK. Together, our findings indicate that OMD deficiency exacerbates bone loss in osteoporosis. Furthermore, OMD may impede osteoclastic differentiation in BMDMs by binding to RANKL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisOsteogenesisOsteoblastsOsteoclastsBone ResorptionExtracellular Matrix ProteinsAnimalsMiceFemaleMice, KnockoutCell DifferentiationOvariectomyRANK LigandMice, Inbred C57BL

Stichwörter der Autor:innen

bone remodeling/regenerationosteoclastogenesisosteoporosisovariectomyrank ligandsmall leucine‐rich proteoglycans

Substanzen

RANK LigandExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Endodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • College of Stomatology, Shanghai Jiao Tong University, Shanghai, China.
  • National Clinical Research Center for Oral Diseases, National Center for Stomatology, Shanghai Key Laboratory of Stomatology, Shanghai, China.
  • State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.

ORCID-Profile: Zhengwei Huang

Förderung

  • the National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality (STCSM)
  • Shanghai Hospital Development Center
  • National Clinical Research Center for Oral Diseases
  • Shanghai Clinical Research Center for Oral Diseases
  • Major and Key Cultivation Projects of Ninth People's Hospital affiliated to Shanghai Jiao Tong university School of Medicine
  • Shanghai's Top Priority Research Center
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Jing, M., Zhu, X., Yang, Y., Hu, X., Tan, W., Liu, X., Zhang, Y., Wang, X., Niu, C., & Huang, Z. (2026). Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis. The FASEB Journal. https://doi.org/10.1096/fj.202600222rr

Vancouver

Jing M, Zhu X, Yang Y, Hu X, Tan W, Liu X, et al. Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis. The FASEB Journal. 2026. doi:10.1096/fj.202600222rr

BibTeX
@article{Jing2026,
  author = {Jing, Meiling and Zhu, Xiaohan and Yang, Yueyi and Hu, Xuchen and Tan, Wenduo and Liu, Xiaoyu and Zhang, Yujie and Wang, Xin and Niu, Chenguang and Huang, Zhengwei},
  title = {Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202600222rr}
}
Kostenlos starten →